We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Futuragene | FGN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 89.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 89.00 | 89.00 |
| Top Posts |
|---|
Posted at 13/5/2010 07:08 by stevepadstow From FGN RNS today:On 23 February 2010, the Company announced that it had received an approach regarding a possible offer for FuturaGene Plc from a third party. Since that date, discussions and due diligence have continued, and an offer of 90p cash per share is announced today. |
Posted at 04/5/2010 20:08 by stevepadstow Chap on LSE mentioned he expected a shareholder meet in 2 weeks time ref T/O. Nothing on FGN site...anyone heard anything...?Cheers |
Posted at 21/4/2010 16:53 by stevepadstow A bit of background reading on Futuragene's market if you have a spare sec. FGN not mentioned but a lot about DuPont & Monsanto et al. |
Posted at 21/4/2010 09:50 by someuwin Personally, I'd be happier if bid was called off. FGN will be worth multiples if left to grow. |
Posted at 20/4/2010 06:14 by ninjapete2 Wrote to FGN last week asking for an update as negotiations seem to be taking a long time for a company of this size. The CEO replied yesterday: "Please be assured that the Board and management are doing everything in their power to develop the company and build shareholder value. We will continue to pursue all avenues that we believe are beneficial to the company and its shareholders and review this process periodically. We will release additional information to the markets as soon as we feel that this is appropriate." No surprises there then. Negotiations are still on going, just a case of wait and see. |
Posted at 13/4/2010 14:53 by someuwin Worth repeating - Evolutions initial coverage of FGN from last october.(Bear in mind that since October we have had news on... poplar trees. Cotton plants with Bayer. Chinese patent for food and non food drought tolerance. Japanese patent for cell wall modification. Chinese licensing agreement for Cotton...) FuturaGene (FGN.L) Buy Trade of the decade Relentless population growth is placing a severe strain on our agricultural resources. By 2020 the world's forests and farms will have to provide timber and food for 800m more people than they do today. The drive to boost crop yields led to a twenty-fold increase in Monsanto's share price in the last decade; we think similar trends will make FuturaGene a stellar performer in the next. Yield-enhancing technology for the forestry and biofuel sectors FuturaGene's genetic technology can boost farm and forestry crop yields by 25-300%, depending on species. It can also accelerate growth, improve stress tolerance and enhance productivity in paper and biofuel processing plants. Billion-dollar customers in billion-dollar markets The Top 10 wood-producing countries exported $100bn of forestry products in 2005, so a 25% yield increase would create more than $25bn of value a year. Unsurprisingly, several major forestry and agricultural players have expressed interest in FuturaGene's technology. Suzano Papel e Celulose (EV $5bn), the world's No2 eucalyptus pulp producer, has contracted to use FuturaGene's technology in its plantations. Suzano has completed a successful three-year trial of FuturaGene's eucalyptus prototypes, and is currently pursuing regulatory approval for commercial deployment. FuturaGene is also working with: the largest supplier of alfalfa seeds in the US; a leading developer and supplier of seedlings for China's forestry industry; a biotech with access to the huge US corn market; one of Thailand's largest forestry companies. If these partnerships progress to plan, we estimate they could generate annual royalties worth tens of millions of dollars. A hidden gem with huge potential Although FuturaGene has made excellent progress with customers in recent years, a legal dispute now fully resolved with the company's founders prevented the current management from promoting the story to investors. We now expect a more active approach to investor relations and positive newsflow from the Suzano partnerships and a significant boost to FuturaGene's profile. Demographic trends suggest that the next decade will be extremely interesting for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology could add billions of dollars to the annual output of the forestry and biofuel industries. Even if FuturaGene captured only a tiny proportion of that value, its profits would dwarf the company's current market cap of £25m. BUY. |
Posted at 23/2/2010 10:58 by someuwin For those that haven't seen it this is the introduction to Evolutions initial coverage of FGN last october.(Bear in mind that since October we have had news on... poplar trees. Cotton plants with Bayer. Chinese patent for food and non food drought tolerance. Japanese patent for cell wall modification. Chinese licensing agreement for Cotton...) FuturaGene (FGN.L) Buy Trade of the decade Relentless population growth is placing a severe strain on our agricultural resources. By 2020 the world's forests and farms will have to provide timber and food for 800m more people than they do today. The drive to boost crop yields led to a twenty-fold increase in Monsanto's share price in the last decade; we think similar trends will make FuturaGene a stellar performer in the next. Yield-enhancing technology for the forestry and biofuel sectors FuturaGene's genetic technology can boost farm and forestry crop yields by 25-300%, depending on species. It can also accelerate growth, improve stress tolerance and enhance productivity in paper and biofuel processing plants. Billion-dollar customers in billion-dollar markets The Top 10 wood-producing countries exported $100bn of forestry products in 2005, so a 25% yield increase would create more than $25bn of value a year. Unsurprisingly, several major forestry and agricultural players have expressed interest in FuturaGene's technology. Suzano Papel e Celulose (EV $5bn), the world's No2 eucalyptus pulp producer, has contracted to use FuturaGene's technology in its plantations. Suzano has completed a successful three-year trial of FuturaGene's eucalyptus prototypes, and is currently pursuing regulatory approval for commercial deployment. FuturaGene is also working with: the largest supplier of alfalfa seeds in the US; a leading developer and supplier of seedlings for China's forestry industry; a biotech with access to the huge US corn market; one of Thailand's largest forestry companies. If these partnerships progress to plan, we estimate they could generate annual royalties worth tens of millions of dollars. A hidden gem with huge potential Although FuturaGene has made excellent progress with customers in recent years, a legal dispute now fully resolved with the company's founders prevented the current management from promoting the story to investors. We now expect a more active approach to investor relations and positive newsflow from the Suzano partnerships and a significant boost to FuturaGene's profile. Demographic trends suggest that the next decade will be extremely interesting for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology could add billions of dollars to the annual output of the forestry and biofuel industries. Even if FuturaGene captured only a tiny proportion of that value, its profits would dwarf the company's current market cap of £25m. BUY. |
Posted at 18/2/2010 14:37 by n_w_b I've done a bit of digging on the Internet, looking into another one of FGN's Licensee's for the use of it's cel1 and cbd genes in alfalfa. The following is taken from Evolution securities "Trade of the Decade" note posted in October 2009, Page 7. "Land O'Lakes is the third-largest cooperative in the US with $12bn in annual sales. Roughly one-third of its revenue comes from animal feed and another third comes from dairy products. The company supplies c60% of America's seeds for alfalfa, a perennial crop used as cattle feed. Alfalfa is deployed across 25m acres in the US, with c4m acres harvested and replanted each year. A Land O'Lakes subsidiary, Forage Genetics, produces transgenic alfalfa seeds using the Roundup Ready genetic trait4, licensed from Monsanto. This makes Forage Genetics the only company to have sold a transgenic perennial crop. Sales commenced in 2005, but have been temporarily halted pending the completion of an environmental impact statement (EIS) by the US Department of Agriculture. Forage Genetics has signed an exclusive licence to use FuturaGene's cel1 and cbd genes in alfalfa, and started its first field trials in summer 2009. If the trials go well, Forage Genetics could be selling seed containing FuturaGene's technology by 2012. Based on current alfalfa prices and the projected yield increase resulting from FuturaGene's technology, we estimate this deal could eventually earn FuturaGene a royalty of c$15/acre. If transgenic alfalfa achieves the same degree of penetration as other transgenic crops in the US, FuturaGene could be looking at a potential royalty opportunity of $50m pa." Unfortunately in 2007 a federal district court issued a ruling that halted planting of Roundup Ready alfalfa until the USDA completes an environmental impact statement (EIS). However it looks like the planting may resume this year, following potential USDA approval. February 15, 2010 USE OF GENETICALLY MODIFIED ALFALFA UNNECESSARILY HELD HOSTAGE Protecting the environment in the 21st century will require the adoption of sophisticated agricultural technologies including biotechnology and genetically modified crops, according to a study by the Royal Society, England's most prestigious scientific body. That's welcome news for America's farmers and consumers. For most of the last two decades the United States has been the undisputed leader in the development and adoption of biotech crops, says Gregory Conko, a senior fellow with the Competitive Enterprise Institute. Ironically, as an increasing number of farmers in Europe, Asia, Africa and South America take up these innovative varieties, burdensome regulations here at home have raised development and approval costs and kept many potentially important products from reaching the market, says Conko:" ..."The USDA issued its environmental impact statement (EIS) in December, and it states unequivocally that biotech and conventional alfalfa can co-exist peacefully." Also: "February 17 2010, Article # 15840 The comment period for a draft environmental impact statement evaluating the potential environmental effects of deregulating alfalfa genetically engineered to be resistant to the herbicide glyphosate, known commercially as Roundup, has been extended 15 days, the USDA's Animal and Plant Health Inspection Service announced yesterday. This genetically engineered alfalfa is commonly referred to as Roundup Ready alfalfa. APHIS considered two alternatives in the draft environmental impact statement: to grant nonregulated status to the two RR alfalfa lines, or to maintain the lines' status as regulated articles. APHIS analyzed these alternatives with regard to their potential environmental impacts, socioeconomic impacts, as well as human health and safety impacts. The comment period will now end on March 3, 2010. APHIS is seeking comment on the draft environmental impact statement and will consider all public comments submitted during the comment period before finalizing the statement or making any decisions regarding the regulatory status of Roundup Ready alfalfa. Preliminarily, APHIS concluded that there is no significant impact on the human environment due to granting nonregulated status to Roundup Ready alfalfa. APHIS is also holding a series of public meetings where interested parties can comment on the draft environmental impact statement. Meetings took place in Nevada and Nebraska earlier this year. The final meeting, which will be held in Riverdale, Md., is now scheduled for Wednesday, February 24, 2010. The meeting will take place from 4 p.m. to 7 p.m. in the APHIS Conference Center, 4700 River Road, Riverdale, Md., 20737. APHIS has regulated the introduction (importation, interstate movement, and environmental release) genetically engineered organisms since 1986 and to date has authorized nearly 16,000 safe environmental releases of these plants and deregulated more than 79 others. My conclusion So with the possible resumption of sales this Spring, FGN could be looking at revenues going forward of $50m pa for Alfalfa, according to the earlier Evolution article. DYOR. |
Posted at 16/2/2010 10:25 by n_w_b RE RNS just released:So Dubai based investor Iraj Parvizi has a stake of 8,809,500 ordinary shares representing approximately 15.67 per cent of FGN. The last RNS I can find, about his previous holding is Which showed himto hold 5,912,000 ordinary shares representing approximately 15.67 per cent of FGN. Thats an increase of 2,897,500 shares sinnce the previous announcement. |
Posted at 06/2/2010 08:59 by n_w_b Taken from this weeks Investors Chronicle's Cover story and main feature on Page 25 entitled "CASH IN ON CROPS"; FGN mentioned as a way of investing in the agricultural space.It talks about the lack of land for agricultural food needs, due to the population increase and how GM could be used to solve the world food shortage to come in the future. Samples taken from the article, well worth anybody picking up a copy for the full read, or subscribing to IC advantage to read. 'With global population growth placing ever-greater demands on the world's food supplies, agricultural investments could be an important store of value for your portfolio.' ...'Merrill Lynch has said it believes agricultural commodities are still in the early stages of a long term bull run' ...'US agribusiness giant Monsanto has the largest share of the GM crop market, but there are numerous agri-biotechs around the world, including the likes of Futuragene and Plant Health care, that offer UK equity exposure to this major trend. The ISAA expects adoption to rise sharply, and estimates that increased concerns over food security and the growing awareness of the environmental benefits of GM will see the number of biotech countries and plantings double by 2015 as new GM strains are introduced. Mr Chandler(of Rabobank) says that GMO's are also being developed that allow crops to withstand even the more extreme weather conditions, such as drought or floods, that are usually responsible for supply shortages.' The last paragraphs referring to one of our technologies, plus ours works in cold climates ;-) The articles also mentions how land is being taken away from food producing, to producing Biofuels. Another one of our technologies. Then on Page 48 of the IC they mention buying Sarasin Agrisar Fund. There's a list of the top 10 investments the fund has; no mention of FGN, although they have a 3.1% holding in Plant Heatlh Care that was mentioined with FGN in the other article as UK stocks to buy for exposure...maybe they'll be buying some FGN soon.IMHO "The Agristar manager has direct access to the Food and Agribusiness Research team at Rabobank, Sarasin's parent company and the world's leading bank focused on the agricultural sector" So that links in nicely with the previous article with comments from Rabobank's Mr Chandler. So where's the largest market in the world...China...and who's anouncing partnerships, patents and working with the forestry department ;-) Then there's our Poplar and eucalyptus projects that are in trails in Brazil that make trees grow quicker and are more dense. Very exciting times ahead, especially when the word gets out in the investment community. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
